223 related articles for article (PubMed ID: 14513374)
1. Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Zell R; Markgraf R; Schmidtke M; Görlach M; Stelzner A; Henke A; Sigusch HH; Glück B
Med Microbiol Immunol; 2004 May; 193(2-3):91-100. PubMed ID: 14513374
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.
Badorff C; Fichtlscherer B; Rhoads RE; Zeiher AM; Muelsch A; Dimmeler S; Knowlton KU
Circulation; 2000 Oct; 102(18):2276-81. PubMed ID: 11056105
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication.
Qiu Y; Ye X; Zhang HM; Hanson P; Zhao G; Tong L; Xie R; Yang D
PLoS Pathog; 2017 Dec; 13(12):e1006744. PubMed ID: 29220410
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide and viral cardiomyopathy.
Finkel MS
Circulation; 2000 Oct; 102(18):2162-4. PubMed ID: 11056085
[No Abstract] [Full Text] [Related]
6. Nitric oxide inhibits viral replication in murine myocarditis.
Lowenstein CJ; Hill SL; Lafond-Walker A; Wu J; Allen G; Landavere M; Rose NR; Herskowitz A
J Clin Invest; 1996 Apr; 97(8):1837-43. PubMed ID: 8621766
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.
Akarid K; Sinet M; Desforges B; Gougerot-Pocidalo MA
J Virol; 1995 Nov; 69(11):7001-5. PubMed ID: 7474119
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.
Müller-Strahl G; Kottenberg K; Zimmer HG; Noack E; Kojda G
J Physiol; 2000 Jan; 522 Pt 2(Pt 2):311-20. PubMed ID: 10639106
[TBL] [Abstract][Full Text] [Related]
9.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
11. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
12. Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Mikami S; Kawashima S; Kanazawa K; Hirata K; Hotta H; Hayashi Y; Itoh H; Yokoyama M
Circ Res; 1997 Oct; 81(4):504-11. PubMed ID: 9314831
[TBL] [Abstract][Full Text] [Related]
13. Effect of isosorbide dinitrate on nitric oxide synthase under hypoxia.
Jiang HB; Yoneyama H; Furukawa A; Hamamoto T; Takahara J; Ichikawa Y
Pharmacology; 2001 Jan; 62(1):10-6. PubMed ID: 11150917
[TBL] [Abstract][Full Text] [Related]
14. NO donors inhibit Leishmania infantum cysteine proteinase activity.
Salvati L; Mattu M; Colasanti M; Scalone A; Venturini G; Gradoni L; Ascenzi P
Biochim Biophys Acta; 2001 Feb; 1545(1-2):357-66. PubMed ID: 11342060
[TBL] [Abstract][Full Text] [Related]
15. Activation of pig oocytes using nitric oxide donors.
Petr J; Rajmon R; Rozinek J; Sedmíková M; Jeseta M; Chmelíková E; Svestková D; Jílek F
Mol Reprod Dev; 2005 May; 71(1):115-22. PubMed ID: 15736132
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.
Jarasch N; Martin U; Kamphausen E; Zell R; Wutzler P; Henke A
Viral Immunol; 2005; 18(2):355-64. PubMed ID: 16035947
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
19. N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.
Jagdeo JM; Dufour A; Klein T; Solis N; Kleifeld O; Kizhakkedathu J; Luo H; Overall CM; Jan E
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437971
[TBL] [Abstract][Full Text] [Related]
20. Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
Thakur NK; Hayashi T; Sumi D; Kano H; Matsui-Hirai H; Tsunekawa T; Iguchi A
J Cardiovasc Pharmacol; 2002 Feb; 39(2):298-309. PubMed ID: 11791016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
